Best Surgical Oncologist in Indore

Brief Profile

Dr. Ritesh Tapkire, a distinguished Senior Cancer Surgeon,With over 15 years of experience and more than 6,500 successful surgeries, Dr. Tapkire is a leading expert in surgical oncology and advanced cancer care. His proficiency spans across minimally invasive cancer surgeries, thoracic oncology, and palliative care, ensuring comprehensive treatment for patients battling cancer.

Dr. Tapkire holds an M.S. and M.Ch in Surgical Oncology from the prestigious Cancer Institute (WIA), Adyar, Chennai. His commitment to excellence is reflected in his advanced training through fellowships in Minimal Access Cancer Surgery (Basavatarakam Indo-American Cancer Hospital, Hyderabad), Video-Assisted Thoracic Surgery (VATS) (Tata Memorial Hospital, Mumbai), Palliative Care (CTC/APHN, AIIMS New Delhi), and Cancer Prevention and Control (NIH, NCI, Maryland, USA).

Driven by a patient-centric approach, Dr. Tapkire combines cutting-edge surgical techniques with compassionate care, ensuring the best possible outcomes for his patients. His expertise and dedication make him an invaluable addition to our oncology team at CARE CHL Hospitals.

Fields of Experience

• VATS esophagectomy
• Laparoscopic colorectal surgeries
• Laparoscopic nephrectomy adrenalectomy
• Laparoscopic pelvic lymphadenectomy
• Surgery for lung Cancer
• Musculoskeletal Cancer Surgery
• Hapeto Pancreatico Biliary Cancer Surgery
• Surgery for Stomach Cancer

Publications

• Original Article: Nizri E, Baratti D, Guaglio M, Sinukumar S, Cabras A, Kusamura S, Deraco M. Multicystic mesothelioma: Operative and long-term outcomes with cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Eur J Surg Oncol. 2018 Jul;44(7):1100-1104. doi: 10.1016/j.ejso.2018.03.004. Epub 2018 Mar 14. PMID: 29703622.
• Original Article: Guaglio M, Sinukumar S, Kusamura S, Milione M, Pietrantonio F, Battaglia L, Guadagni S, Baratti D, Deraco M. Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series. Ann Surg Oncol. 2018 Apr;25(4):878-884. doi: 10.1245/s10434-018-6341-9. Epub 2017 Dec 21. Erratum in: Ann Surg Oncol. 2018 Jan 19;: PMID: 29270877.
• Original Article: Shigeki Kusamura, Sinukumar  Snita, Marcello Guaglio, Baratti Dario, Marcello Deraco. Cytoreductive Surgery and HIPEC in the First-Line and Interval Time Points of Advanced Epithelial Ovarian Cancer December 2017 Indian Journal of Gynecologic Oncology 15(S1):11-20 December 2017 15(S1):11-20, DOI:10.1007/s40944-017-0148-7
• Original Article: Nag, S., Sinukumar S, and Hegde, S. Germline Testing for Predisposition to Breast/Ovarian Cancer Should Only be Offered to Selected Patients with Epithelial Ovarian Cancer, Indian J Gynecol Oncolog (2017) 15(Suppl 1): 31 
• Original Article: Bhatt A, Bakrin N, Kammar P, Mehta S, Sinukumar S, Parikh L, Shaikh S, Mishra S, Mallaya M, Kepenekian V, Benzerdjeb N, Glehen O. Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications. Eur J Surg Oncol. 2021 Jan;47(1):181-187. doi: 10.1016/j.ejso.2020.10.012. Epub 2020 Oct 14. PMID: 33071172.
• Original Article: Bhatt A, Kammar P, Mehta S, Damodaran D, Zaveri S, Patel MD, Sinukumar S, Ray M, Seshadri R. Chasing Rainbows? the Possibility of "Cure" in Patients with Colorectal Peritoneal Metastases Undergoing Cytoreductive Surgery and HIPEC-a Retrospective Study by INDEPSO. Indian J Surg Oncol. 2019 Feb;10(Suppl 1):49-56. doi: 10.1007/s13193-019-00879-9. Epub 2019 Jan 30. PMID: 30886494; PMCID: PMC6397129
• Original Article: Bhatt A, Kammar P, Mehta S, Damodaran D, Zaveri S, Patel MD, Sinukumar S, Ray M, Seshadri R. Chasing Rainbows? the Possibility of "Cure" in Patients with Colorectal Peritoneal Metastases Undergoing Cytoreductive Surgery and HIPEC-a Retrospective Study by INDEPSO. Indian J Surg Oncol. 2019 Feb;10(Suppl 1):49-56. doi: 10.1007/s13193-019-00879-9. Epub 2019 Jan 30. PMID: 30886494; PMCID: PMC6397129.
• Original Article: Solanki SL, Mukherjee S, Agarwal V, Thota RS, Balakrishnan K, Shah SB, Desai N, Garg R, Ambulkar RP, Bhorkar NM, Patro V, Sinukumar S, Venketeswaran MV, Joshi MP, Chikkalingegowda RH, Gottumukkala V, Owusu-Agyemang P, Saklani AP, Mehta SS, Seshadri RA, Bell JC, Bhatnagar S, Divatia JV. Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Indian J Anaesth. 2019 Dec;63(12):972-987. doi: 10.4103/ija.IJA_765_19. Epub 2019 Dec 11. PMID: 31879421; PMCID: PMC6921319.

Education

• MBBS from S.S. Medical College, Rewa (M.P.); 1995 - 2001
• M.S. (General Surgery) from M.G.M. Medical college, Indore (M.P.); 2001-2004 
• M.Ch. (Surgical Oncology) Cancer Institute (WIA), Adyar, Chennai 2007-2010

Languages Known

Hindi, English

Fellowship/Membership

• Fellowship in Minimal Access Cancer Surgery – Basavatarakam Indo-American Cancer Hospital & Research Centre, Hyderabad
• Fellowship in VATS (Video-Assisted Thoracic Surgery) – TMH, Mumbai
• Fellowship in Palliative Care – CTC/APHN (AIIMS, New Delhi)
• Fellowship in Cancer Prevention and Control – NIH, NCI, Maryland, USA

Past Positions

• Deputy Director: Cachar Cancer Hospital and Research Centre, Silchar; 01/01/2017 to 31/12/24 
• Surgical Oncologist Head: Cachar Cancer Hospital and Research Centre, Silchar; Aug 2013 to Jan 2017
• Surgical Oncologist: Cachar Cancer Hospital and Research Centre, Silchar; Sep 2010 to Aug 2013
• Registrar Surgical Oncologist: Cancer Institute(WIA),Adyar,Chennai; Oct 2005 to Mar 2007
• Senior Resident Surgical Oncologist: Fortis Jessaram Hospital, New Delhi; Sep 2004 to June 2005